CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

826_ext_01_0.png

Net Sales by Sales Format

826_ext_02_0.png

Ordinary Income

826_ext_03_0.png

Net Income

826_ext_04_0.png

Business Results Data (Cons.)

Unit:million yen

 
  FY 2014 FY 2015 FY 2016 FY 2017 FY 2018(Est.)
Net Sales 9,939 9,650 10,003 10,393 10,750

Cost of Sales
(% of Net Sales)

5,684
57.2%
5,438
56.4%
5,499
55.0%
5,471
52.6%
5,598
52.1%

Gross Profit
(% of Net Sales)

4,255
42.8%
4,211
43.6%
4,503
45.0%
4,922
47.4%
5,152
47.9%

SG&A expenses
(% of Net Sales)

3,471
34.9%
3,563
36.9%
3,748
37.5%
4,068
39.1%
4,217
39.2%

Operating Income 
(% of Net Sales)

784
7.9%
648
6.7%
754
7.5%
854
8.2%
935
8.7%

Ordinary Income 
(% of Net Sales)

1,002
10.1%
654
6.8%
821
8.2%
880
8.5%
950
8.8%

Net Income
(% of Net Sales)

490
4.9%
333
3.5%
516
5.2%
467
4.5%
670
6.2%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2014 FY 2015 FY 2016 FY 2017 FY 2018(Est.)

Own-brand
(%)

6,438
64.8%
6,441
66.8%
6,263
62.6%
6,402
61.6%
6,550
60.9%
OEM Sales
(%)
1,673
16.8%
1,526
15.8%
1,784
17.8%
1,576
15.2%
1,489
13.9%
Overseas
(%)
1,827
18.4%
1,682
17.4%
1,954
19.6%
2,414
23.2%
2,711
25.2%
Total
(%)
9,939
100.0%
9,650
100.0%
10,003
100.0%
10,393
100.0%
10,750
100.0%

Graph Showing Financial Position

826_ext_07_0.png

Free Cash Flow

826_ext_08_0.png

Financial Position Data(cons.)

Unit:million yen

  
  FY 2014 FY 2015 FY 2016 FY 2017 FY 2018(Est.)

Current Assets

11,421 10,708 11,433 11,126 11,390

Fixed Assets

6,485 6,482 6,178 6,133 5,888

Total Assets
(Gross Assets)

17,906 17,191 17,611 17,259 17,278

Current Liabilities

3,007 2,718 3,294 3,052 2,838

Fixed Liabilities

2,002 1,329 1,713 1,337 1,449

Total Liabilities

5,009 4,047 5,007 4,390 4,287

Shareholders' Equity

12,897 13,143 12,603 12,868 12,990

Equity Ratio

72.0% 76.5% 71.6% 74.6% 75.2%

Cash Flow Data

Unit:million yen

  FY 2014 FY 2015 Fy 2016 FY 2017 FY 2018
(Est.)

Net cash provided by (used in) operating activities

1,223 715 1,443 524 706

Net cash provided by (used in) investing activities

607 △ 492 △ 270 △ 193 △ 202

Net cash provided by (used in) financing activities

△ 709 △ 584 △ 332 △ 652 △ 538

Net increase(decrease)in cash and cash equivalents

1,186 △ 431 719 △ 313 △ 34

Cash and cash equivalents at end of year

4,139 3,708 4,427 4,114 4,079

Free Cash Flow

1,830 223 1,173 331 504
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2014 FY 2015 FY 2016 FY 2017 FY 2018(Est.)
ROE 3.9% 2.6% 4.0% 3.7% 5.2%
EPS(yen) 50.96 34.64 54.73 50.23 71.92
BPS(yen) 1,341.24 1,366.83 1,352.97 1,381.40 1,394.55

Dividend per Share (yen)

35 35 35 35 35

Dividend Payout Ratio(cons.)

68.7% 101.0% 64.0% 69.7% 48.7%

TOP